Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Correlation of Intrathoracic Impedance Measures With Blood Plasma Volume in Congestive Heart Failure (Optivol)

This study has been completed.
Sponsor:
Collaborator:
Medtronic
Information provided by (Responsible Party):
Adrian Van Bakel, Medical University of South Carolina
ClinicalTrials.gov Identifier:
NCT00603213
First received: January 16, 2008
Last updated: May 21, 2013
Last verified: May 2013
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: February 2011
  Primary Completion Date: October 2010 (Final data collection date for primary outcome measure)